Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis

Tong Zhou, Wei Zhang, Nadera J. Sweiss, Edward S. Chen, David R. Moller, Kenneth S. Knox, Shwu Fan Ma, Michael S. Wade, Imre Noth, Roberto Machado, Joe G.N. Garcia

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ~20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.

Original languageEnglish (US)
Article numbere44818
JournalPLoS One
Volume7
Issue number9
DOIs
StatePublished - Sep 12 2012
Externally publishedYes

Fingerprint

Biomarkers
Sarcoidosis
Gene expression
biomarkers
Blood
Genes
genomics
Gene Expression
gene expression
blood
genes
T-lymphocytes
lungs
Cytokine Receptors
T-cells
T-Cell Antigen Receptor
cytokines
Lung
Cytokines
receptors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Zhou, T., Zhang, W., Sweiss, N. J., Chen, E. S., Moller, D. R., Knox, K. S., ... Garcia, J. G. N. (2012). Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis. PLoS One, 7(9), [e44818]. https://doi.org/10.1371/journal.pone.0044818

Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis. / Zhou, Tong; Zhang, Wei; Sweiss, Nadera J.; Chen, Edward S.; Moller, David R.; Knox, Kenneth S.; Ma, Shwu Fan; Wade, Michael S.; Noth, Imre; Machado, Roberto; Garcia, Joe G.N.

In: PLoS One, Vol. 7, No. 9, e44818, 12.09.2012.

Research output: Contribution to journalArticle

Zhou, T, Zhang, W, Sweiss, NJ, Chen, ES, Moller, DR, Knox, KS, Ma, SF, Wade, MS, Noth, I, Machado, R & Garcia, JGN 2012, 'Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis', PLoS One, vol. 7, no. 9, e44818. https://doi.org/10.1371/journal.pone.0044818
Zhou, Tong ; Zhang, Wei ; Sweiss, Nadera J. ; Chen, Edward S. ; Moller, David R. ; Knox, Kenneth S. ; Ma, Shwu Fan ; Wade, Michael S. ; Noth, Imre ; Machado, Roberto ; Garcia, Joe G.N. / Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis. In: PLoS One. 2012 ; Vol. 7, No. 9.
@article{69ba860c4c7644b49138042c539a5e41,
title = "Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis",
abstract = "Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ~20{\%} of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86{\%} classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.",
author = "Tong Zhou and Wei Zhang and Sweiss, {Nadera J.} and Chen, {Edward S.} and Moller, {David R.} and Knox, {Kenneth S.} and Ma, {Shwu Fan} and Wade, {Michael S.} and Imre Noth and Roberto Machado and Garcia, {Joe G.N.}",
year = "2012",
month = "9",
day = "12",
doi = "10.1371/journal.pone.0044818",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis

AU - Zhou, Tong

AU - Zhang, Wei

AU - Sweiss, Nadera J.

AU - Chen, Edward S.

AU - Moller, David R.

AU - Knox, Kenneth S.

AU - Ma, Shwu Fan

AU - Wade, Michael S.

AU - Noth, Imre

AU - Machado, Roberto

AU - Garcia, Joe G.N.

PY - 2012/9/12

Y1 - 2012/9/12

N2 - Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ~20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.

AB - Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ~20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.

UR - http://www.scopus.com/inward/record.url?scp=84866329023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866329023&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0044818

DO - 10.1371/journal.pone.0044818

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e44818

ER -